Showing results (1421-1430 of 1,640) with videos related to

Sort By:
Pageof 164
Proceedings of the National Academy of Sciences of the United States of America|February 5, 2024
Acceleration of infectious disease drug discovery and development using a humanized model of drug metabolismA Kenneth MacLeod, Kevin-Sebastien Coquelin, Leticia Huertas, et al.
Journal of Translational Medicine|July 9, 2026
Bridging preclinical development and clinical manufacturing: a translational GMP-Platform for lentiviral vector production in academic CAR T-Cell therapyMaribel Lara-Chica, Blanca Arribas-Arribas, Raquel Muñoz-García, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 3, 2024
Activity and resistance mechanisms of the third generation tetracyclines tigecycline, eravacycline and omadacycline against nationwide Spanish collections of carbapenemase-producing Enterobacterales and Acinetobacter baumanniiPatricia García, Paula Guijarro-Sánchez, Cristina Lasarte-Monterrubio, et al.
ESMO Open|November 24, 2020
Neoadjuvant treatment for locally advanced unresectable and borderline resectable pancreatic cancer: oncological outcomes at a single academic centreSusana Roselló, Claudio Pizzo, Marisol Huerta, et al.
Cancer Prevention Research (Philadelphia, Pa.)|December 5, 2020
Targeting of CD40 and PD-L1 Pathways Inhibits Progression of Oral Premalignant Lesions in a Carcinogen-induced Model of Oral Squamous Cell CarcinomaJose A Monteiro de Oliveira Novaes, Taghreed Hirz, Irene Guijarro, et al.
Nutrients|March 6, 2021
Nutritional Components in Western Diet Versus Mediterranean Diet at the Gut Microbiota-Immune System Interplay. Implications for Health and DiseaseCielo García-Montero, Oscar Fraile-Martínez, Ana M Gómez-Lahoz, et al.
Cancers|September 9, 2022
Real-World Data on Chronic Myelomonocytic Leukemia: Clinical and Molecular Characteristics, Treatment, Emerging Drugs, and Patient OutcomesSandra Castaño-Díez, Mónica López-Guerra, Cristina Bosch-Castañeda, et al.
Cancer Cell|August 4, 2009
Targeted activation of innate immunity for therapeutic induction of autophagy and apoptosis in melanoma cellsDamià Tormo, Agnieszka Checińska, Direna Alonso-Curbelo, et al.
Cancers|May 11, 2024
Feasibility and Acute Toxicity of Hypo-Fractionated Radiotherapy on 0.35T MR-LINAC: The First Prospective Study in SpainDaniela Gonsalves, Abrahams Ocanto, Eduardo Meilan, et al.
Antimicrobial Agents and Chemotherapy|January 10, 2025
Advancements in the fight against globally distributed OXA-48 carbapenemase: evaluating the new generation of carbapenemase inhibitorsMichelle Outeda-García, Jorge Arca-Suárez, Emilio Lence, et al.
Pageof 164